Literature DB >> 6977542

Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines.

D A Wiginton, J J Hutton.   

Abstract

Adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) was examined in human lymphoblast cell lines from normal and adenosine deaminase-deficient individuals as well as individuals heterozygous for adenosine deaminase deficiency. Adenosine deaminase activity was determined by a specific enzymatic assay and compared to immunoreactive adenosine deaminase protein (or cross-reacting material) determined by radioimmunoassay, in order to investigate mutations affecting adenosine deaminase. Two different antisera, raised in goat and rabbit against human adenosine deaminase, had different sensitivities and apparent specificities when used for radioimmunoassay. Rabbit antisera provided the most sensitive assay of normal enzyme, whereas goat antiserum provided the most sensitive assay for detection of mutant proteins. A wide range of values for the ratio of immunoreactive protein to activity was observed for the adenosine deaminase deficient cell lines, ranging from near normal to 23 times normal. The cell lines with high ratios appear to contain large amounts of catalytically defective or inactive protein. The amount of mutant protein detected by radioimmunoassay in the deficient cell lines depends upon the antiserum utilized, making as much as a 50-fold difference. The heterozygous lines contain approximately half of the normal amounts of immunoreactive protein and activity, and thus have a normal ratio of the two. Two cell lines partially deficient in adenosine deaminase appear to contain large amounts of an unstable adenosine deaminase protein with partially impaired activity. Immunoreactive protein was visualized in extracts from several cell lines, after electrophoresis and transfer to activated paper, by labeling with immunological probes and autoradiography.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977542

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

2.  Sequence of human adenosine deaminase cDNA including the coding region and a small intron.

Authors:  D A Wiginton; G S Adrian; J J Hutton
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

3.  Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.

Authors:  P E Daddona; B S Mitchell; H J Meuwissen; B L Davidson; J M Wilson; C A Koller
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

4.  Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.

Authors:  A L Akeson; D A Wiginton; J C States; C M Perme; M R Dusing; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Transient expression of human adenosine deaminase cDNAs: identification of a nonfunctional clone resulting from a single amino acid substitution.

Authors:  S H Orkin; S C Goff; W N Kelley; P E Daddona
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

6.  Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.

Authors:  D T Bonthron; A F Markham; D Ginsburg; S H Orkin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.

Authors:  D Valerio; M G Duyvesteyn; H van Ormondt; P Meera Khan; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

9.  Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.

Authors:  E Herbschleb-Voogt; J W Scholten; P Meera Khan
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  Adenylosuccinate synthetase and adenylosuccinate lyase deficiencies trigger growth and infectivity deficits in Leishmania donovani.

Authors:  Jan M Boitz; Rona Strasser; Phillip A Yates; Armando Jardim; Buddy Ullman
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.